French Polynesia

French Polynesia

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

Children under-5 years
Download
Value (%) Year Type Source
0 (0 - 0.50) 2014 Survey/reported WHO WPRO, Woodring J et al, 2017
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
Eligible for HBV generic medicines
Source: MPP
Eligible for HCV generic medicines
Source: MPP

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
1.56 (1.18 - 5.38) 2019 Modelled Dugan et al., 2021
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

Women of childbearing age (15–49 years)
Download
Value Year Type Source
1,100 (850 - 3,900) 2019 Modelled Dugan et al., 2021

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
Eligible for HBV generic medicines
Source: MPP
Eligible for HCV generic medicines
Source: MPP

Overview

Prevalence (national)

Modelled

No data available
No data available

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

No data available

Survey/surveillance

No data available
HBV chart

Modelled

No data available

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0 (%)
2014, survey/surveillance
(0 - 0.50(%))
WHO WPRO, Woodring J et al, 2017

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources

Programs

Partners